Published in J Intern Med on November 01, 1997
Investigating Serotonin Signalling in IBD Patients (IBD) | NCT01650311
Homeostasis and inflammation in the intestine. Cell (2010) 4.60
Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol (2013) 1.57
Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology (2010) 1.27
Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol (2010) 1.23
Real-time measurement of serotonin release and motility in guinea pig ileum. J Physiol (2006) 1.22
Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides (2012) 1.16
IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil (2008) 1.13
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci (2002) 1.04
Serotonin and GI Disorders: An Update on Clinical and Experimental Studies. Clin Transl Gastroenterol (2012) 1.01
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol (2008) 0.98
Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol (2014) 0.95
Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers. Gastroenterol Res Pract (2015) 0.91
The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med (2012) 0.90
Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br J Pharmacol (2011) 0.88
High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol (2012) 0.88
5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Br J Pharmacol (2013) 0.87
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci (2012) 0.87
Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol (2000) 0.84
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
5-HT7 receptor signaling: improved therapeutic strategy in gut disorders. Front Behav Neurosci (2014) 0.81
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxf) (2015) 0.81
Association of Serotonin Transporter Promoter Polymorphism (5-HTTLPR) with Microscopic Colitis and Ulcerative Colitis. Dig Dis Sci (2014) 0.80
Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus. Br J Pharmacol (2015) 0.80
Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis. Inflammation (2013) 0.79
Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol (2013) 0.79
Expression of melatonin synthesizing enzymes in Helicobacter pylori infected gastric mucosa. Biomed Res Int (2013) 0.78
5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis. Br J Pharmacol (2016) 0.78
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1. Front Immunol (2016) 0.77
Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon. Mediators Inflamm (2016) 0.77
Dual regulatory role for phosphatase and tensin homolog in specification of intestinal endocrine cell subtypes. World J Gastroenterol (2012) 0.77
Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis. Int J Mol Med (2016) 0.76
Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats. Mol Med Rep (2016) 0.76
VIP immunoreactive nerves and somatostatin and serotonin containing cells in Crohn's disease. World J Gastroenterol (1999) 0.76
Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis. Mol Med Rep (2016) 0.75
A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients. Can J Gastroenterol (2013) 0.75
Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid. Int J Gen Med (2011) 0.75
Association of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive? Dig Dis Sci (2015) 0.75
Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. Int J Mol Med (2016) 0.75
Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism. Sci Rep (2017) 0.75
Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis. Front Pharmacol (2016) 0.75
Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats. Mol Med Rep (2016) 0.75
Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease? F1000Res (2015) 0.75
Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handb Exp Pharmacol (2016) 0.75
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
A silver nitrate stain for alpha-2 cells in human pancreatic islets. Acta Soc Med Ups (1968) 3.93
Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int (1998) 2.60
A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med (1994) 2.58
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun (1989) 1.77
Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet (1998) 1.77
Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol (2003) 1.70
Walking training of patients with hemiparesis at an early stage after stroke: a comparison of walking training on a treadmill with body weight support and walking training on the ground. Clin Rehabil (2001) 1.69
Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol (2001) 1.64
The potential of the immunogold-silver staining method for paraffin sections. Histochemistry (1984) 1.60
Low folate levels may protect against colorectal cancer. Gut (2006) 1.60
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Features of Sjögren's syndrome in patients with primary biliary cirrhosis. J Intern Med (1991) 1.58
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology (1996) 1.58
Estimation of the parenchymal-cell content of the parathyroid gland, using density-gradient columns. Preliminary report. Acta Pathol Microbiol Scand A (1977) 1.52
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer (2002) 1.51
Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J (1988) 1.51
Spatial properties of nutrient concentrations in the Baltic Sea. Environ Monit Assess (1995) 1.50
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther (2012) 1.49
Lateral rectal ligaments contain important nerves. Br J Surg (1997) 1.47
Amyloid in polypeptide hormone-producing tumors. Lab Invest (1977) 1.45
The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A (1973) 1.43
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery. Colorectal Dis (2006) 1.39
Oncocytic tumor of the pancreas. Report of a case with aspiration cytology. Acta Cytol (1990) 1.39
Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med (1994) 1.39
Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery (1975) 1.38
[Different anamnestic approaches in the treatment of dyspepsia. Quicker access to gastroscopy should make the diagnosis easier]. Lakartidningen (2000) 1.38
Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemic sulfonylureas. Diabetes (1969) 1.36
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol (1995) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol (2004) 1.35
A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis (1997) 1.33
Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol (2000) 1.33
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31
Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol (1980) 1.27
Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol (1993) 1.25
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut (1996) 1.25
Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol (1988) 1.24
Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol (1975) 1.22
The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker". Pathol Res Pract (1989) 1.21
Pulmonary function in adolescent idiopathic scoliosis: a 25 year follow up after surgery or start of brace treatment. Thorax (2001) 1.20
Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic and normal glands. Acta Pathol Microbiol Scand A (1977) 1.20
Identification of the intestinal cell storing gastric inhibitory peptide. Histochemistry (1975) 1.19
Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg (1992) 1.19
Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum (1998) 1.17
Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol (1995) 1.17
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther (1994) 1.14
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis (2002) 1.13
Studies on the active site of deacetoxycephalosporin C synthase. J Mol Biol (1999) 1.13
The argyrophil reaction in islet cells of adult human pancreas studies with a new silver nitrate procedure. Acta Soc Med Ups (1968) 1.12
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol (1991) 1.12
Techniques for measuring amylase secretion from pieces of mouse pancreas. Anal Biochem (1974) 1.12
The parathyroid glands in experimentally induced hypergastrinemia in the rat. Scand J Gastroenterol (1977) 1.12
Acute liver failure in Sweden: etiology and outcome. J Intern Med (2007) 1.11
The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. Eur J Biochem (1978) 1.11
Clinical management of gastric carcinoid tumors. Digestion (1994) 1.10
Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization. J Pathol (1999) 1.10
Neuroendocrine tumors of the gastrointestinal tract. Pathol Res Pract (1988) 1.10
COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10
Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry (1983) 1.08
Parathyroid adenomas and glands in normocalcemic hyperparathyroidism. A light microscopic study. Am J Pathol (1976) 1.08
Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol (1999) 1.08
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. Gut (1990) 1.07
Colchicine treatment of primary sclerosing cholangitis. Gastroenterology (1995) 1.07
Estimation of parenchymal cell content of human parathyroid glands using the image analyzing computer technique. Am J Pathol (1978) 1.07
Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol (1993) 1.07
Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case-control study in Sweden and Norway. Cancer Causes Control (1997) 1.06
Studies on the non-adenomatous glands in patients with a solitary parathyroid adenoma. Ups J Med Sci (1976) 1.05
Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med (2003) 1.05
Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int (1998) 1.05
Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther (1993) 1.04
Argyrophil carcinoid tumors of the lung. Incidence, clinical study, and follow-up of 46 patients. Chest (1980) 1.04
Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. Acta Med Scand (1980) 1.04
Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg (1998) 1.03
Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer (1998) 1.03
A simple index for assessment of disease activity in patients with ulcerative colitis. Hepatogastroenterology (1990) 1.03
Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem (1997) 1.03
Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am J Pathol (1978) 1.02
Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol (2000) 1.02
Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract (1987) 1.02
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab (1998) 1.02
Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Hum Pathol (1996) 1.02
Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol (1988) 1.01
Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis (1999) 1.01
Medical diagnostic x rays and thyroid cancer. J Natl Cancer Inst (1995) 1.01
P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis (1995) 1.01
Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem (1986) 1.01
Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol (1997) 1.00
Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer (1999) 1.00
Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J Biol Chem (1987) 1.00
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res (2000) 1.00